Accepted at 3:43 p.m. Mar, 18, 2024 by Cameron
Author: GroupG_Strep93
Co-authors: Cameron
Related Note: 1462979594244
Rationale for change

wording (testosterone is already active, just conversion to more active form DHT is inhibited)
Source: AMBOSS - https://next.amboss.com/us/article/pi0Lsf?q=finesteride#Z014baf92567dac3d7590c72481d57792

Text Text
Extra
- 5α-reductase inhibitors take 6-12 months for symptom improvement (prostate volume reduction) to be appreciable; thus used along with α-blockers as they provide quick relief

- Adverse effects include gynecomastia; excess testosterone that isn't being converted to DHT can be converted to estrogen peripherally

- May also be used to prevent hair loss in males

Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid

Sketchy
Watch Benign Prostatic Hyperplasia (BPH) & Prostate Cancer
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo



Bootcamp
Watch associated Bootcamp video - Benign Prostatic Hyperplasia

Watch associated Bootcamp video - Antiandrogens
OME

Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#FirstAid::15_Repro::05_Pharm::15_Antiandrogens::Finasteride #AK_Step1_v12::#Costanzo::Repro::03_Male_Reproductive_Physiology #AK_Step1_v12::^Other::^EXPN::BGedit #AK_Step1_v12::#UWorld::Step::1726 #AK_Step1_v12::#UWorld::COMLEX::23770 #AK_Step1_v12::#UWorld::Step::658 #AK_Step1_v12::#UWorld::Step::587 #AK_Step1_v12::#FirstAid::15_Repro::05_Pharm::15_Antiandrogens #AK_Step1_v12::#FirstAid::15_Repro::03_Physiology::16_Androgens #AK_Step2_v12::#AMBOSS::YKanUl #AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_Reproductive::Reproductive_Physiology_+_Anatomy/Embryo #AK_Step1_v12::#FirstAid::15_Repro::03_Physiology::16_Androgens::Testosterone_Synthesis #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::^Systems::Reproductive::Physiology #AK_Step1_v12::#UWorld::COMLEX::24837 #AK_Step1_v12::#Physeo::09_Pharm::12_Reproductive::10_Antiandrogens #AK_Step1_v12::#Bootcamp::Reproduction::06_Pharmacology::04_Antiandrogens #AK_Step1_v12::#UWorld::COMLEX::25956 #AK_Step1_v12::#B&B::20_Repro::06_Male_Disorders::04_Prostate #AK_Step1_v12::#B&B::08_Endocrinology::04_Repro::02_Male_Repro_Hormones #AK_Step1_v12::#UWorld::COMLEX::25469 #AK_Step1_v12::#UWorld::COMLEX::23700 #AK_Step1_v12::#Pathoma::14_Male::04_Prostate #AK_Step1_v12::#FirstAid::15_Repro::04_Pathology::38_Benign_Prostatic_Hyperplasia::Treatment !AK_UpdateTags::Step1decks::Zanki-Step-Decks::Zanki-Reproductive::Reproductive-Physiology+Anatomy/Embryo #AK_Step1_v12::#SketchyPath::08_Repro_&_GU::05_Male_GU::02_Benign_Prostatic_Hyperplasia_(BPH)_&_Prostate_Cancer #AK_Step1_v12::#AMBOSS::E0a83Q #AK_Step1_v12::#Bootcamp::Reproduction::05_Male_Pathology::08_Benign_Prostatic_Hyperplasia #AK_Step1_v12::#AMBOSS::YKanUl #AK_Step1_v12::#FirstAid::15_Repro::04_Pathology::38_Benign_Prostatic_Hyperplasia #AK_Step1_v12::#OME::PreClinical::Renal::Renal_3:_Bladder::Prostate #AK_Step1_v12::#Pixorize::03_Pharmacology::19_Reproductive_Pharm::14_Finasteride #AK_Step1_v12::#AMBOSS::o5a0OO #AK_Step1_v12::^Other::^EXPN::Uworld !AK_UpdateTags::AnKing_Image::Aiman #AK_Step1_v12::#UWorld::Step::8930 #AK_Step1_v12::#UWorld::Step::14818